Kamyar Farahi

Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

A. Gottlieb, K. Papp, A. Kavanaugh, 2018, BMC Rheumatology.

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial.

E. Grice, E. Muñoz-Elías, A. Blauvelt, 2018, The Journal of investigative dermatology.

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

B. Strober, L. Gensler, Subrata Ghosh, 2019, Drug Safety.

Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis

W. Olson, C. Carter, S. Brenneman, 2015, Patient preference and adherence.

A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis

T. Brown, C. Ellis, C. Carter, 2015, The Journal of dermatological treatment.

Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis

C. Carter, B. Essoi, Mingliang Zhang, 2015 .